UnitedHealth Group (UNH) stock has experienced a dramatic shift in 2025, dropping from a peak of $675 in March to approximately $308.88 by September 1, 2025. This bearish trend, driven by rising medical costs and a Medicare Advantage utilization surge, offers a compelling case for technical analysis using Fibonacci retracement, regression trend, and projection tools. Understanding these methods can help investors navigate UNH’s market volatility effectively.

Fibonacci retracement identifies critical support and resistance levels based on the stock’s high-to-low movement. Key levels include $638.32 (0.236), $483.19 (0.382), and $394.09 (0.618), with the current price breaking below the 0.618 mark, signaling a strong bearish reversal. This tool, combined with MACD’s negative divergence, highlights potential buying opportunities during short-term rebounds.

The regression trend, depicted as a downward-sloping channel on the chart, quantifies UNH’s bearish momentum. The price, now near the channel’s midline, suggests continued decline unless a significant reversal occurs. This statistical approach, paired with declining OBV (On-Balance Volume), confirms the loss of bullish strength since April 2025.

Since May, analysts have consistently pegged the stock's price target between $198 and $325. Based on Fibonacci extensions and regression channels, this target reflects ongoing challenges like DOJ investigations and CEO turnover. Investors should monitor healthcare cost trends, as a potential rebound from the bottom could occur if negative news runs its course.